Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Observational Study Designed to Investigate the Utilisation and Effectiveness of Originator and Biosimilar Anti-TNF Agents in Australian Rheumatology

NCT03470688 is registered in ClinicalTrials.gov with Opal Rheumatology Ltd. as lead sponsor.

NCT NCT03470688
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03470688 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Observational Study Designed to Investigate the Utilisation and Effectiveness of Originator and Biosimilar Anti-TNF Agents in Australian Rheumatology
Lead sponsor
Opal Rheumatology Ltd.
Phase
Observational
Overall status
Unknown status
Start date
March 1, 2018
Completion date
December 31, 2021
Enrollment
5,000 (estimated)
Sites
22

Conditions

As the registry lists them; a condition with its own page is linked.

ankylosing spondylitis, psoriatic arthritis, rheumatoid arthritis